NASDAQ:IMPV - Imperva Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$51.90 -0.55 (-1.05 %)
(As of 06/17/2018 04:00 PM ET)
Previous Close$51.90
Today's Range$51.5010 - $52.75
52-Week Range$37.17 - $53.95
Volume429,179 shs
Average Volume235,333 shs
Market Capitalization$1.80 billion
P/E RatioN/A
Dividend YieldN/A

About Imperva (NASDAQ:IMPV)

Imperva logoImperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustrySystems Software
SectorComputer and Technology


Debt-to-Equity RatioN/A
Current Ratio2.82
Quick Ratio2.82


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$321.72 million
Price / Sales5.60
Cash Flow$0.0559 per share
Price / Cash928.14
Book Value$9.26 per share
Price / Book5.60


EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Net Margins-3.00%
Return on Equity-1.63%
Return on Assets-0.97%


Outstanding Shares34,690,000

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva Inc (NASDAQ:IMPV) announced its quarterly earnings data on Thursday, April, 26th. The software maker reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. The software maker earned $84.24 million during the quarter, compared to analyst estimates of $83.77 million. Imperva had a negative return on equity of 1.63% and a negative net margin of 3.00%. The firm's revenue for the quarter was up 16.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.09 EPS. View Imperva's Earnings History.

When is Imperva's next earnings date?

Imperva is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Imperva.

What price target have analysts set for IMPV?

15 brokerages have issued 12-month price targets for Imperva's shares. Their forecasts range from $39.00 to $67.00. On average, they expect Imperva's stock price to reach $53.00 in the next twelve months. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:
  • 1. BTIG Research analysts commented, "Imperva posted a strong beat on Non-GAAP EPS, a moderate beat on revenues, and weaker than expected billings, deferred revenues, operating margin and cash flows. Disruptions in the North American salesforce during the quarter seems to have created challenges in delivering the results. While Asia Pacific seems to have been off to a strong start, with Europe following, without the North America engine in full throttle, Imperva cannot get to its destination. We like management’s vision to transform into a hybrid cybersecurity leader, but until we see tangible outcomes, we are forced to remain on the sidelines. Maintain Neutral." (4/29/2018)
  • 2. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:
  • Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
  • Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
  • Mr. Aharon Strosberg, VP of Operations
  • Mr. Terry Ray, Chief Technology Officer

Has Imperva been receiving favorable news coverage?

Press coverage about IMPV stock has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imperva earned a coverage optimism score of 0.10 on Accern's scale. They also gave headlines about the software maker an impact score of 46.34 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Imperva's major shareholders?

Imperva's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.52%), Eagle Asset Management Inc. (3.82%), ETF Managers Group LLC (3.31%), Millennium Management LLC (2.10%), Rothschild Asset Management Inc. (1.44%) and Northern Trust Corp (1.19%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.

Which institutional investors are selling Imperva stock?

IMPV stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., North Run Capital LP, ETF Managers Group LLC, Millennium Management LLC, Wells Fargo & Company MN, Smith Asset Management Group LP and Point72 Asset Management L.P.. Company insiders that have sold Imperva company stock in the last year include Anthony J Bettencourt and Michael D Mooney. View Insider Buying and Selling for Imperva.

Which institutional investors are buying Imperva stock?

IMPV stock was purchased by a variety of institutional investors in the last quarter, including Legal & General Group Plc, Impax Asset Management LLC, Hsbc Holdings PLC, Highbridge Capital Management LLC, Segall Bryant & Hamill LLC, Broadview Advisors LLC, Roystone Capital Management LP and Prudential Financial Inc.. View Insider Buying and Selling for Imperva.

How do I buy shares of Imperva?

Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of IMPV stock can currently be purchased for approximately $51.90.

How big of a company is Imperva?

Imperva has a market capitalization of $1.80 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]

MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  585 (Vote Outperform)
Underperform Votes:  308 (Vote Underperform)
Total Votes:  893
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imperva (NASDAQ:IMPV) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $53.00, suggesting that the stock has a possible upside of 2.12%. The high price target for IMPV is $67.00 and the low price target for IMPV is $39.00. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyHold
Consensus Rating Score: 2.402.472.502.41
Ratings Breakdown: 2 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.00$53.6154$53.1538$52.00
Price Target Upside: 2.12% upside18.23% upside14.19% upside24.25% upside

Imperva (NASDAQ:IMPV) Consensus Price Target History

Price Target History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/14/2018StephensBoost Price TargetOverweight$61.00 ➝ $67.00HighView Rating Details
4/29/2018BTIG ResearchReiterated RatingHoldMediumView Rating Details
4/27/2018Evercore ISIReiterated RatingBuy$56.00HighView Rating Details
4/23/2018Royal Bank of CanadaReiterated RatingBuy$54.00LowView Rating Details
4/10/2018DA DavidsonInitiated CoverageBuy ➝ Buy$56.00HighView Rating Details
2/9/2018Imperial CapitalBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $55.00LowView Rating Details
2/9/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$37.00 ➝ $39.00HighView Rating Details
2/9/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$52.00HighView Rating Details
12/12/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$45.00HighView Rating Details
11/9/2017OppenheimerReiterated RatingBuy$55.00N/AView Rating Details
11/9/2017Stifel NicolausReiterated RatingHold ➝ Hold$50.00 ➝ $47.00N/AView Rating Details
10/24/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/10/2017William BlairDowngradeOutperform ➝ Market PerformN/AView Rating Details
10/9/2017Wells Fargo & CoDowngradeOutperform ➝ Market PerformN/AView Rating Details
7/28/2017Monness Crespi & HardtBoost Price TargetBuy$55.00 ➝ $57.00HighView Rating Details
6/7/2017Susquehanna BancsharesInitiated CoveragePositive ➝ Positive$60.00LowView Rating Details
6/6/2017UBS GroupInitiated CoveragePositive$60.00N/AView Rating Details
11/4/2016NomuraReiterated RatingHold$37.50N/AView Rating Details
11/4/2016Needham & Company LLCUpgradeHold ➝ Buy$64.00 ➝ $43.00N/AView Rating Details
11/4/2016MacquarieUpgradeNeutral ➝ OutperformN/AView Rating Details
10/22/2016Buckingham ResearchReiterated RatingNeutral$45.00N/AView Rating Details
10/15/2016Deutsche BankReiterated RatingHoldN/AView Rating Details
9/25/2016JMP SecuritiesReiterated RatingOutperform$50.00 ➝ $56.00N/AView Rating Details
9/13/2016WunderlichInitiated CoverageHold$50.00N/AView Rating Details
8/30/2016Pacific CrestDowngradeOverweight ➝ Sector Weight$47.00 ➝ $30.00N/AView Rating Details
(Data available from 6/17/2016 forward)


Imperva (NASDAQ:IMPV) Earnings History and Estimates Chart

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Earnings Estimates

2018 EPS Consensus Estimate: ($1.61)
2019 EPS Consensus Estimate: $0.63
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.60)($0.60)($0.60)
Q2 20181($0.51)($0.51)($0.51)
Q3 20181($0.50)($0.50)($0.50)
Q1 20191$0.02$0.02$0.02
Q2 20191$0.10$0.10$0.10
Q3 20191$0.19$0.19$0.19
Q4 20191$0.32$0.32$0.32

Imperva (NASDAQ IMPV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2018($0.33)N/AView Earnings Details
4/26/2018Q1 2018$0.19$0.26$83.77 million$84.24 millionViewN/AView Earnings Details
2/8/2018Q4 2017$0.27$0.40$91.11 million$91.10 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.22$0.33$83.79 million$83.89 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.05($0.10)$74.30 million$74.44 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.62)($0.29)$68.16 million$72.31 millionViewListenView Earnings Details
2/8/2017Q416$0.03$0.32$70.22 million$78.40 millionViewListenView Earnings Details
11/3/2016Q316($0.16)$0.08$63.10 million$68.40 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.23)$66.06 million$57.87 millionViewListenView Earnings Details
5/5/2016Q116($0.28)($0.25)$59.65 million$59.80 millionViewListenView Earnings Details
2/3/2016Q415$0.15$0.20$68.11 million$72.70 millionViewListenView Earnings Details
10/29/2015Q3($0.05)$0.19$56.52 million$63.30 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.08)$48.40 million$53.50 millionViewListenView Earnings Details
5/7/2015Q115($0.38)($0.26)$40.50 million$44.80 millionViewListenView Earnings Details
2/5/2015Q414($0.04)($0.04)$49.80 million$51.40 millionViewListenView Earnings Details
10/30/2014Q314($0.63)($0.51)$40.00 million$42.70 millionViewListenView Earnings Details
7/31/2014Q2 2014($0.72)($0.59)$38.44 millionViewN/AView Earnings Details
5/1/2014Q114($0.41)($0.36)$31.73 million$31.50 millionViewListenView Earnings Details
2/6/2014Q413$0.11$0.12$41.63 million$42.70 millionViewListenView Earnings Details
11/5/2013Q313($0.05)($0.01)$34.43 million$35.10 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)($0.10)$31.38 million$31.30 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.10)($0.13)$27.49 million$28.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.02$0.06$29.91 million$31.80 millionViewListenView Earnings Details
11/1/2012Q3 2012($0.07)($0.08)ViewN/AView Earnings Details
8/9/2012($0.05)($0.02)ViewN/AView Earnings Details
5/3/2012($0.13)($0.12)ViewN/AView Earnings Details
2/9/2012($0.15)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Imperva (NASDAQ:IMPV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.10%
Insider Trading History for Imperva (NASDAQ:IMPV)
Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Anthony J BettencourtDirectorSell66,037$46.98$3,102,418.2666,037View SEC Filing  
2/20/2018Michael D MooneyCROSell24,454$47.18$1,153,739.7224,454View SEC Filing  
8/24/2017Anthony J BettencourtDirectorSell99,598$43.59$4,341,476.8299,598View SEC Filing  
5/16/2017Sunil D NagdevSVPSell4,857$49.00$237,993.0016,290View SEC Filing  
5/15/2017Amichai ShulmanInsiderSell3,089$48.70$150,434.30100,151View SEC Filing  
5/10/2017Michael D MooneyCROSell52,356$47.51$2,487,433.5652,356View SEC Filing  
4/17/2017Amichai ShulmanInsiderSell3,085$41.97$129,477.4599,151View SEC Filing  
3/15/2017Amichai ShulmanInsiderSell3,085$41.85$129,107.2599,151View SEC Filing  
2/28/2017Mark E KraynakSVPSell45,314$41.63$1,886,421.8210,064View SEC Filing  
2/21/2017Anthony J BettencourtChairmanSell84,863$45.55$3,865,509.6584,863View SEC Filing  
2/21/2017Terrence J SchmidCFOSell4,500$45.53$204,885.00432View SEC Filing  
2/16/2017Mark E KraynakSVPSell1,731$46.10$79,799.103,858View SEC Filing  
2/15/2017Amichai ShulmanInsiderSell3,085$45.91$141,632.3595,713View SEC Filing  
1/17/2017Amichai ShulmanCTOSell3,085$40.60$125,251.00View SEC Filing  
12/21/2016Amichai ShulmanInsiderSell3,085$40.00$123,400.0091,830View SEC Filing  
11/16/2016Mark E KraynakSVPSell3,332$40.16$133,813.12448View SEC Filing  
11/15/2016Amichai ShulmanInsiderSell3,085$40.10$123,708.5092,000View SEC Filing  
10/17/2016Amichai ShulmanInsiderSell3,085$48.57$149,838.4591,062View SEC Filing  
10/3/2016Amichai ShulmanInsiderSell938$53.27$49,967.2695,085View SEC Filing  
9/23/2016Amichai ShulmanInsiderSell937$51.00$47,787.0095,084View SEC Filing  
9/23/2016Mark E. KraynakSVPSell5,582$51.00$284,682.00View SEC Filing  
9/15/2016Amichai ShulmanInsiderSell3,085$44.30$136,665.5094,147View SEC Filing  
8/16/2016Mark E KraynakSVPSell2,614$47.73$124,766.223,552View SEC Filing  
8/15/2016Amichai ShulmanInsiderSell3,085$46.87$144,593.9594,317View SEC Filing  
7/27/2016Amichai ShulmanInsiderSell3,085$46.28$142,773.8093,380View SEC Filing  
7/26/2016Mark E KraynakSVPSell2,967$46.15$136,927.052,968View SEC Filing  
6/23/2016Shlomo KramerMajor ShareholderSell75,000$45.12$3,384,000.001,304,521View SEC Filing  
6/20/2016Shlomo KramerMajor ShareholderSell75,000$40.24$3,018,000.001,304,521View SEC Filing  
5/31/2016Terrence J SchmidCFOSell5,000$37.66$188,300.00335View SEC Filing  
5/25/2016Anthony J BettencourtCEOSell50,000$36.15$1,807,500.0052,938View SEC Filing  
5/19/2016Shlomo KramerMajor ShareholderSell50,000$34.20$1,710,000.001,304,521View SEC Filing  
5/17/2016Shlomo KramerMajor ShareholderSell75,000$33.95$2,546,250.001,304,521View SEC Filing  
5/16/2016Terrence J SchmidCFOSell7,000$33.99$237,930.008,053View SEC Filing  
5/12/2016Shlomo KramerMajor ShareholderSell75,000$34.16$2,562,000.001,304,521View SEC Filing  
3/31/2016Mark E. KraynakSVPSell2,758$50.00$137,900.00View SEC Filing  
3/1/2016Amichai ShulmanCTOSell3,000$45.25$135,750.0089,527View SEC Filing  
2/24/2016Terrence J SchmidCFOSell6,500$41.82$271,830.007,468View SEC Filing  
2/17/2016Mark E KraynakSVPSell2,758$40.04$110,430.322,758View SEC Filing  
2/8/2016Albert A PimentelDirectorBuy5,000$38.93$194,650.004,475View SEC Filing  
2/8/2016Amichai ShulmanCTOSell4,150$38.12$158,198.0082,590View SEC Filing  
2/1/2016Amichai ShulmanCTOSell3,000$50.49$151,470.0086,740View SEC Filing  
1/4/2016Amichai ShulmanCTOSell5,812$60.36$350,812.3286,740View SEC Filing  
12/1/2015Amichai ShulmanCTOSell3,000$74.22$222,660.0086,740View SEC Filing  
11/19/2015Mark E. KraynakinsiderSell10,000$75.00$750,000.00View SEC Filing  
11/19/2015Tram T. PhiVPSell1,244$73.26$91,135.445,975View SEC Filing  
11/16/2015Anthony J. BettencourtCEOSell50,000$69.33$3,466,500.008,489View SEC Filing  
11/16/2015Mark E. KraynakinsiderSell3,789$68.73$260,417.97View SEC Filing  
11/12/2015Shlomo KramerMajor ShareholderSell100,000$71.65$7,165,000.001,259,521View SEC Filing  
11/6/2015Shlomo KramerMajor ShareholderSell50,000$72.14$3,607,000.001,259,521View SEC Filing  
11/4/2015Shlomo KramerMajor ShareholderSell25,000$72.05$1,801,250.001,259,521View SEC Filing  
11/4/2015Terrence J. SchmidCFOSell938$71.14$66,729.32View SEC Filing  
11/3/2015Shlomo KramerMajor ShareholderSell25,000$72.55$1,813,750.001,259,521View SEC Filing  
10/1/2015Amichai ShulmanCTOSell2,813$65.00$182,845.0084,802View SEC Filing  
8/31/2015Terrence J. SchmidCFOSell1,595$61.56$98,188.20View SEC Filing  
8/17/2015Mark E KraynakInsiderSell1,520$71.42$108,558.40View SEC Filing  
7/23/2015Amichai ShulmanCTOSell9,000$70.00$630,000.00View SEC Filing  
5/11/2015Amichai ShulmanCTOSell10,313$51.09$526,891.17View SEC Filing  
5/11/2015Mark E KraynakInsiderSell4,000$55.00$220,000.00View SEC Filing  
4/20/2015Mark E KraynakInsiderSell3,000$47.53$142,590.00View SEC Filing  
1/20/2015Mark E KraynakInsiderSell3,000$44.60$133,800.00View SEC Filing  
1/8/2015Amichai ShulmanCTOSell1,875$50.00$93,750.00View SEC Filing  
12/16/2014Amichai ShulmanCTOSell9,492$50.00$474,600.00View SEC Filing  
12/15/2014Amichai ShulmanCTOSell11,133$50.00$556,650.00View SEC Filing  
12/1/2014Amichai ShulmanCTOSell5,000$42.44$212,200.00View SEC Filing  
11/28/2014Yaniv ShayaVPSell2,512$44.00$110,528.00View SEC Filing  
11/20/2014Mark E KraynakInsiderSell6,140$42.00$257,880.00View SEC Filing  
11/14/2014Yaniv ShayaVPSell20,938$44.52$932,159.76View SEC Filing  
11/13/2014Mark E KraynakInsiderSell2,000$45.00$90,000.00View SEC Filing  
11/11/2014Tram T PhiVPSell10,076$43.50$438,306.00View SEC Filing  
11/4/2014Terrence J SchmidCFOSell20,000$40.73$814,600.00View SEC Filing  
11/3/2014Amichai ShulmanCTOSell5,000$41.09$205,450.00View SEC Filing  
10/31/2014Amichai ShulmanCTOSell7,500$36.56$274,200.00View SEC Filing  
10/31/2014Mark E KraynakInsiderSell2,000$36.56$73,120.00View SEC Filing  
10/6/2014Amichai ShulmanCTOSell2,500$30.00$75,000.00View SEC Filing  
9/2/2014Amichai ShulmanCTOSell5,000$30.00$150,000.00View SEC Filing  
8/21/2014Terrence J SchmidCFOSell15,000$29.07$436,050.00View SEC Filing  
5/23/2014Ralph PisaniVPSell8,613$21.31$183,543.03View SEC Filing  
5/21/2014Terrence SchmidCFOSell15,000$21.26$318,900.002,853View SEC Filing  
4/7/2014Shlomo KramerCEOSell60,000$50.53$3,031,800.001,229,521View SEC Filing  
4/2/2014Shlomo KramerCEOSell40,000$55.67$2,226,800.001,229,521View SEC Filing  
1/8/2014Shlomo KramerCEOSell20,000$50.10$1,002,000.001,219,521View SEC Filing  
1/7/2014Shlomo KramerCEOSell40,000$49.99$1,999,600.001,219,521View SEC Filing  
1/3/2014Shlomo KramerCEOSell40,000$48.31$1,932,400.001,219,521View SEC Filing  
1/2/2014Amichai ShulmanCTOSell22,875$47.68$1,090,680.0010,000View SEC Filing  
12/17/2013Amichai ShulmanCTOSell10,090$45.00$454,050.0010,000View SEC Filing  
12/2/2013Amichai ShulmanCTOSell12,410$44.13$547,653.3010,000View SEC Filing  
11/26/2013Yaniv ShayaVPSell5,243$43.92$230,272.565,000View SEC Filing  
11/21/2013Jason ForgetSVPSell8,558$38.98$333,590.84View SEC Filing  
11/21/2013Terrence SchmidCFOSell11,100$40.26$446,886.00View SEC Filing  
11/21/2013Tram PhiVPSell6,646$39.50$262,517.00View SEC Filing  
11/19/2013Mark KraynakVPSell3,190$37.80$120,582.0015,000View SEC Filing  
8/29/2013Yaniv ShayaVPSell4,375$48.00$210,000.00View SEC Filing  
8/26/2013Jason ForgetSVPSell2,500$47.50$118,750.00View SEC Filing  
8/26/2013Yaniv ShayaVPSell5,000$47.71$238,550.00View SEC Filing  
8/23/2013Terrence SchmidCFOSell2,539$47.20$119,840.80View SEC Filing  
8/21/2013Jason ForgetSVPSell2,500$47.00$117,500.00View SEC Filing  
8/20/2013Terrence SchmidCFOSell10,461$47.03$491,980.83View SEC Filing  
8/16/2013Jason ForgetSVPSell2,062$47.00$96,914.00View SEC Filing  
8/14/2013Tram PhiVPSell5,000$46.00$230,000.00View SEC Filing  
8/13/2013Jason ForgetSVPSell2,000$45.01$90,020.00View SEC Filing  
8/13/2013Mark KraynakVPSell10,000$44.41$444,100.0015,000View SEC Filing  
8/5/2013Amichai ShulmanCTOSell1,086$52.58$57,101.88View SEC Filing  
8/2/2013Amichai ShulmanCTOSell46,140$51.87$2,393,281.80View SEC Filing  
7/3/2013Amichai ShulmanCTOSell3,222$45.21$145,666.62View SEC Filing  
7/1/2013Amichai ShulmanCTOSell16,778$44.94$754,003.32View SEC Filing  
6/3/2013Amichai ShulmanCTOSell20,000$39.49$789,800.00View SEC Filing  
5/30/2013Amichai ShulmanCTOSell10,000$39.93$399,300.00View SEC Filing  
5/30/2013Yaniv ShayaVPSell4,375$40.40$176,750.00View SEC Filing  
5/29/2013Amichai ShulmanCTOSell20,000$39.96$799,200.00View SEC Filing  
5/28/2013Tram T PhiVPSell5,000$40.25$201,250.00View SEC Filing  
5/24/2013Yaniv ShayaVPSell2,250$40.00$90,000.00View SEC Filing  
5/14/2013Yaniv ShayaVPSell10,000$39.00$390,000.00View SEC Filing  
5/13/2013Albert A PimentelDirectorSell10,000$37.93$379,300.00View SEC Filing  
5/13/2013Ralph PisaniVPSell5,000$38.46$192,300.00View SEC Filing  
5/13/2013Terrence J SchmidCFOSell13,000$37.75$490,750.00View SEC Filing  
5/8/2013Jason ForgetSVPSell4,063$37.31$151,590.53View SEC Filing  
3/26/2013Amichai ShulmanCTOSell20,000$38.30$766,000.00View SEC Filing  
2/26/2013Amichai ShulmanCTOSell20,000$36.05$721,000.00View SEC Filing  
12/28/2012Amichai ShulmanCTOSell10,000$31.01$310,100.00View SEC Filing  
12/27/2012Amichai ShulmanCTOSell20,000$30.98$619,600.00View SEC Filing  
12/5/2012Michael BoodaeiDirectorSell30,000$31.48$944,400.00View SEC Filing  
11/27/2012Amichai ShulmanCTOSell20,000$29.06$581,200.00View SEC Filing  
11/7/2012James R TolonenDirectorBuy5,000$31.17$155,850.00View SEC Filing  
11/1/2012Amichai ShulmanCTOSell20,000$31.71$634,200.00View SEC Filing  
10/4/2012Michael BoodaeiDirectorSell30,000$34.03$1,020,900.00View SEC Filing  
9/5/2012Michael BoodaeiDirectorSell20,000$30.35$607,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Imperva (NASDAQ IMPV) News Headlines

Imperva Reaches Analyst Target PriceImperva Reaches Analyst Target Price - June 15 at 4:46 PM
Imperva (IMPV) Price Target Increased to $67.00 by Analysts at StephensImperva (IMPV) Price Target Increased to $67.00 by Analysts at Stephens - June 14 at 12:10 PM
Stephens raises its Imperva target to 30% upsideStephens raises its Imperva target to 30% upside - June 14 at 9:01 AM
Imperva Claims About Auth0 Are Misleading At BestImperva Claims About Auth0 Are Misleading At Best - June 12 at 4:37 PM
Imperva (IMPV) Receives Average Recommendation of "Hold" from AnalystsImperva (IMPV) Receives Average Recommendation of "Hold" from Analysts - June 7 at 7:38 PM
$87.22 Million in Sales Expected for Imperva (IMPV) This Quarter$87.22 Million in Sales Expected for Imperva (IMPV) This Quarter - June 7 at 2:30 AM
 Brokerages Anticipate Imperva (IMPV) Will Post Earnings of -$0.33 Per Share Brokerages Anticipate Imperva (IMPV) Will Post Earnings of -$0.33 Per Share - June 5 at 5:32 PM
Imperva Unveils Attack Analytics to Speed Identification of the Most Critical AttacksImperva Unveils Attack Analytics to Speed Identification of the Most Critical Attacks - May 29 at 8:59 AM
Survey Reveals More Than 1 in 3 Healthcare Organizations Have Suffered a Cyberattack While 1 in 10 Have Paid a RansomSurvey Reveals More Than 1 in 3 Healthcare Organizations Have Suffered a Cyberattack While 1 in 10 Have Paid a Ransom - May 23 at 8:54 AM
Cloudera (CLDR) versus Imperva (IMPV) Head-To-Head ContrastCloudera (CLDR) versus Imperva (IMPV) Head-To-Head Contrast - May 20 at 7:22 PM
-$0.33 EPS Expected for Imperva (IMPV) This Quarter-$0.33 EPS Expected for Imperva (IMPV) This Quarter - May 19 at 1:23 PM
Form 4 IMPERVA INC For: May 15 Filed by: Phi Tram TForm 4 IMPERVA INC For: May 15 Filed by: Phi Tram T - May 18 at 9:42 AM
Imperva Ranks Top DDoS Attack Protection, 2018 Black Book Market Research Cybersecurity User SurveyImperva Ranks Top DDoS Attack Protection, 2018 Black Book Market Research Cybersecurity User Survey - May 14 at 9:46 AM
Imperva (IMPV) Receives Consensus Recommendation of "Hold" from AnalystsImperva (IMPV) Receives Consensus Recommendation of "Hold" from Analysts - May 13 at 7:36 PM
Imperva to Present at Upcoming ConferencesImperva to Present at Upcoming Conferences - May 8 at 9:05 AM
 Brokerages Anticipate Imperva (IMPV) Will Announce Quarterly Sales of $87.22 Million Brokerages Anticipate Imperva (IMPV) Will Announce Quarterly Sales of $87.22 Million - May 4 at 4:54 AM
 Brokerages Anticipate Imperva (IMPV) to Announce $0.22 Earnings Per Share Brokerages Anticipate Imperva (IMPV) to Announce $0.22 Earnings Per Share - May 2 at 1:24 AM
Edited Transcript of IMPV earnings conference call or presentation 26-Apr-18 9:00pm GMTEdited Transcript of IMPV earnings conference call or presentation 26-Apr-18 9:00pm GMT - April 30 at 4:42 PM
Imperva (IMPV) Given "Hold" Rating at BTIG ResearchImperva (IMPV) Given "Hold" Rating at BTIG Research - April 29 at 9:17 AM
Imperva (IMPV) Releases Quarterly  Earnings Results, Beats Expectations By $0.07 EPSImperva (IMPV) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - April 27 at 5:58 PM
Imperva -2.3% after Q1 beats, in-line guide with expected tax chargeImperva -2.3% after Q1 beats, in-line guide with expected tax charge - April 27 at 4:43 PM
Market Trends Toward New Normal in Acacia Research, A10 Networks, Imperva, PotlatchDeltic, Blackhawk Network ...Market Trends Toward New Normal in Acacia Research, A10 Networks, Imperva, PotlatchDeltic, Blackhawk Network ... - April 27 at 9:34 AM
Imperva (IMPV) Q1 2018 Results - Earnings Call TranscriptImperva (IMPV) Q1 2018 Results - Earnings Call Transcript - April 27 at 9:34 AM
BRIEF-Imperva Reports Q1 GAAP Loss Per Share Of $0.28BRIEF-Imperva Reports Q1 GAAP Loss Per Share Of $0.28 - April 27 at 9:34 AM
Imperva (IMPV) Given Buy Rating at Evercore ISIImperva (IMPV) Given Buy Rating at Evercore ISI - April 27 at 6:26 AM
Imperva Announces First Quarter 2018 Financial ResultsImperva Announces First Quarter 2018 Financial Results - April 26 at 4:43 PM
Imperva (IMPV) option implied volatility elevated into EPS and outlookImperva (IMPV) option implied volatility elevated into EPS and outlook - April 25 at 9:07 AM
Imperva (IMPV) Scheduled to Post Quarterly Earnings on WednesdayImperva (IMPV) Scheduled to Post Quarterly Earnings on Wednesday - April 25 at 3:16 AM
Imperva (IMPV) Receives Buy Rating from Royal Bank of CanadaImperva (IMPV) Receives Buy Rating from Royal Bank of Canada - April 23 at 6:30 AM
Imperva (IMPV) Downgraded by ValuEngine to SellImperva (IMPV) Downgraded by ValuEngine to Sell - April 19 at 2:58 PM
Imperva Inc (IMPV) Given Consensus Recommendation of "Hold" by BrokeragesImperva Inc (IMPV) Given Consensus Recommendation of "Hold" by Brokerages - April 18 at 7:24 PM
Imperva (IMPV) Lifted to "Buy" at BidaskClubImperva (IMPV) Lifted to "Buy" at BidaskClub - April 17 at 9:57 AM
$84.16 Million in Sales Expected for Imperva Inc (IMPV) This Quarter$84.16 Million in Sales Expected for Imperva Inc (IMPV) This Quarter - April 17 at 5:01 AM
Imperva (IMPV) Stock Rating Lowered by BidaskClubImperva (IMPV) Stock Rating Lowered by BidaskClub - April 16 at 9:48 AM
Zacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Earnings of $0.19 Per ShareZacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Earnings of $0.19 Per Share - April 15 at 1:17 AM
North American Database Security Market Report 2018 - Data Privacy Laws are Driving the MarketNorth American Database Security Market Report 2018 - Data Privacy Laws are Driving the Market - April 13 at 4:47 PM
Analysts Set Expectations for Imperva Incs Q1 2019 Earnings (IMPV)Analysts Set Expectations for Imperva Inc's Q1 2019 Earnings (IMPV) - April 13 at 9:31 AM
DA Davidson Offers 4 Reasons To Like ImpervaDA Davidson Offers 4 Reasons To Like Imperva - April 12 at 9:54 AM
DA Davidson starts Imperva at 27% upsideDA Davidson starts Imperva at 27% upside - April 12 at 9:54 AM
Imperva Appoints David Woodcock to Lead Worldwide SalesImperva Appoints David Woodcock to Lead Worldwide Sales - April 11 at 4:47 PM
Imperva (IMPV) Downgraded by Zacks Investment ResearchImperva (IMPV) Downgraded by Zacks Investment Research - April 11 at 9:52 AM
Evercore ISI Reiterates "$56.00" Price Target for Imperva (IMPV)Evercore ISI Reiterates "$56.00" Price Target for Imperva (IMPV) - April 10 at 8:54 PM
Imperva (IMPV) Coverage Initiated at DA DavidsonImperva (IMPV) Coverage Initiated at DA Davidson - April 10 at 5:02 PM
Imperva (IMPV) Upgraded to Hold by BidaskClubImperva (IMPV) Upgraded to Hold by BidaskClub - April 9 at 12:59 AM
Imperva (IMPV) Downgraded by William Blair to "Market Perform"Imperva (IMPV) Downgraded by William Blair to "Market Perform" - April 7 at 6:04 PM
Imperva (IMPV) PT Lowered to $50.00 at Imperial CapitalImperva (IMPV) PT Lowered to $50.00 at Imperial Capital - April 7 at 4:58 PM
Piper Jaffray Downgrades Imperva (IMPV) to NeutralPiper Jaffray Downgrades Imperva (IMPV) to Neutral - April 7 at 12:26 PM
What Are Analysts Saying About The Future Of Imperva Inc’s (NASDAQ:IMPV)?What Are Analysts Saying About The Future Of Imperva Inc’s (NASDAQ:IMPV)? - April 4 at 9:14 AM
Stifel Nicolaus Reaffirms Hold Rating for Imperva (IMPV)Stifel Nicolaus Reaffirms Hold Rating for Imperva (IMPV) - March 31 at 7:10 PM
Impervas (IMPV) "Underweight" Rating Reaffirmed at Morgan StanleyImperva's (IMPV) "Underweight" Rating Reaffirmed at Morgan Stanley - March 31 at 5:28 PM

SEC Filings

Imperva (NASDAQ:IMPV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement


Imperva (NASDAQ IMPV) Stock Chart for Sunday, June, 17, 2018

Loading chart…

This page was last updated on 6/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.